...
首页> 外文期刊>OncoTargets and therapy >MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in papillary thyroid carcinoma
【24h】

MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in papillary thyroid carcinoma

机译:MicroRNA-26a-5p通过抑制Wnt5a在甲状腺乳头状癌中的表达来抑制增殖,侵袭和转移

获取原文
           

摘要

Background: Thyroid cancer (TC) is considered as the fastest growing malignancy in the human endocrine system, particularly papillary thyroid cancer (PTC). MicroRNAs (miRs) serve as a role in promoting or suppressing tumors in various types of malignant tumor including PTC. This study aims to explore whether microRNA-26a-5p (miR-26a-5p) could affect the proliferation, invasion and metastasis ability of PTC cells by regulating Wnt5a. Materials and methods: The expression of miR-26a-5p was examined by qRT-PCR in PTC tissue samples (58 cases, mean age 53 years old) and PTC cell lines (K1 and BCPAP). Cell proliferation, invasion and migration were tested with CCK8 assay, colony formation assay, transwell invasion assay and wound healing assay, respectively. Luciferase reporting experiment was used to verify that Wnt5a is a molecular target of miR-26a-5p. The relationship between miR-26a-5p and Wnt5a was analyzed by qRT-PCR and Western blot and was further proved by Pearson’s correlation analysis. Animal (24 nude mice) experiments were used to demonstrate that miR-26a-5p inhibits tumor growth by targeting Wnt5a. Results: The expression of miR-26a-5p declined in PTC tissues ( P 0.01). The expression of miR-26a-5 was also significantly down-regulated in PTC tissues with advanced TNM stages ( P 0.01) and lymph node metastasis ( P 0.01) compared with normal thyroid tissues.?Compared with normal human thyroid cell line Nthy-ori 3-1, the expression of miR-26a-5p in K1 cells and BCPAP cells were nearly 4.02-fold ( P 0.01) and 2.51-fold ( P 0.01) reduced. Up regulation of miR-26a-5p inhibited proliferation, colony formation, invasion and migration of PTC cells. MiR-26a-5p negatively regulated Wnt5a expression ( r =?0.887, P 0.01), yet Wnt5a overexpression reversed the tumor-suppressive effect of miR-26a-5p in PTC. Animal experiments further verified that miR-26a-5p inhibited PTC growth by targeting Wnt5a. Conclusion: Overexpression of miR-26a-5p depresses proliferation, invasion, metastasis of PTC via Wnt5a. Therefore, miR-26a-5p may represent a potentially effective target gene for PTC.
机译:背景:甲状腺癌(TC)被认为是人类内分泌系统中发展最快的恶性肿瘤,特别是乳头状甲状腺癌(PTC)。 MicroRNA(miR)在包括PTC在内的各种类型的恶性肿瘤中起到促进或抑制肿瘤的作用。本研究旨在探讨microRNA-26a-5p(miR-26a-5p)是否可以通过调节Wnt5a来影响PTC细胞的增殖,侵袭和转移能力。材料和方法:通过qRT-PCR检测miR-26a-5p在PTC组织样本(58例,平均年龄53岁)和PTC细胞系(K1和BCPAP)中的表达。细胞增殖,侵袭和迁移分别用CCK8测定,集落形成测定,transwell侵袭测定和伤口愈合测定来测试。萤光素酶报告实验用于验证Wnt5a是miR-26a-5p的分子靶标。通过qRT-PCR和Western blot分析了miR-26a-5p和Wnt5a之间的关系,并通过Pearson的相关分析进一步证明了这一点。动物(24只裸鼠)实验用于证明miR-26a-5p通过靶向Wnt5a抑制肿瘤生长。结果:miR-26a-5p在PTC组织中的表达下降(P <0.01)。与正常甲状腺组织相比,在晚期TNM分期(P <0.01)和淋巴结转移(P <0.01)的PTC组织中,miR-26a-5的表达也显着下调。与正常人甲状腺细胞系Nthy比较-ori 3-1,miR-26a-5p在K1细胞和BCPAP细胞中的表达降低了近4.02倍(P <0.01)和2.51倍(P <0.01)。上调miR-26a-5p抑制PTC细胞的增殖,集落形成,侵袭和迁移。 MiR-26a-5p负调控Wnt5a表达(r =?0.887,P <0.01),而Wnt5a过表达逆转了miR-26a-5p在PTC中的肿瘤抑制作用。动物实验进一步验证了miR-26a-5p通过靶向Wnt5a抑制PTC生长。结论:miR-26a-5p的过表达抑制了Wnt5a对PTC的增殖,侵袭和转移。因此,miR-26a-5p可能代表PTC的潜在有效靶基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号